Clinical Trial Update: Multi-Center Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD (PINNACLE 2) [Phase 3]

View source ↗

Summary

Phase 3 PINNACLE 2 trial evaluating the efficacy and safety of PT003, PT005, and PT001 in adults with moderate to very severe COPD has completed, with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• PT001
• PT003
• PT005

Snippet

Sponsor: Pearl Therapeutics, Inc. | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 3 | Status: COMPLETED | Results posted: 2017-03-28